Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life

by Benucci M, Damiani A, Manfredi M, Infantino M, Grossi V, Li Gobbi F
Published 2019-06-01

Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis

by Benucci M, Bandinelli F, Damiani A, Li Gobbi F, Infantino M, Grossi V, Manfredi M
Published 2018-06-01

Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data

by Benucci M, Damiani A, Li Gobbi F, Grossi V, Infantino M, Manfredi M, Niccoli L, Cantini F
Published 2020-04-01

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases

by Benucci M, Damiani A, Li Gobbi F, Bandinelli F, Infantino M, Grossi V, Manfredi M, Noguier G, Meacci F
Published 2018-01-01

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab

by Benucci M, Meacci F, Grossi V, Infantino M, Manfredi M, Bellio E, Bellio V, Li Gobbi F, Bazzichi L, Moscato P, Caputo D, Saviola G, Talotta R, Sarzi-Puttini P, Atzeni F
Published 2016-03-01

Development of new photon detection device for Cherenkov and fluorescence radiation

by Tinti A., Scarselli M., Santucci S., Pignatel G., Passacantando M., Nappi E., Guarino F., Grossi V., Maddalena P., Fiandrini E., Cilmo M., De Crescenzi M., Castrucci P., Ambrosio M., Battiston R., Aramo C., Ambrosio A., Valentini A.
Published 2013-06-01